CoChat

Correlation Between tRNALys3 Aminoacylation and Its Incorporation into HIV-1

Open access
Javanbakht, Hassan, Cen, Shan, Musier-Forsyth, Karin, Kleiman, Lawrence · 2002 · Journal of Biological Chemistry

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

Abstract

During human immunodeficiency virus type 1 (HIV-1) assembly, tRNA(Lys) is selectively packaged into the virus, where tRNA(Lys3) serves as the primer for reverse transcription. Lysyl-tRNA synthetase is also selectively incorporated into HIV-1 and is therefore a strong candidate for being the signal by which viral proteins interact with tRNA(Lys) isoacceptors. Previously, mutations in the tRNA(Lys3) anticodon have been shown to strongly inhibit the charging of tRNA(Lys3) by lysyl-tRNA synthetase in vitro, and we show here that in vivo aminoacylation is also inhibited by anticodon changes. The order of decreasing in vivo aminoacylation for tRNA(Lys3) anticodon mutants is: wild-type SUU (where S = mcm(5)S(2)U) 100%) --> SGU (49%) --> CGU (40%) --> SGA (0%) and CGA (0%). We found that the ability of these tRNA(Lys3) anticodon variants to be aminoacylated in vivo is directly correlated with their ability to be packaged into HIV-1. These data showed that the anticodon is a major determinant for tRNA(Lys3) packaging and support the conclusion that its productive interaction with lysyl-tRNA synthetase is important for tRNA(Lys3) incorporation into HIV-1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112479200

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1 Sequence of human tRNA Lys3 folded into the cloverleaf secondary structure. The arrows point to the anticodon mutations created in this work, and the mutant tRNA species are listed as well. Sequences complementary to the DNA hybridization probes are indicated by the solid lines . The probe complementary to the 3 ′ -18 nucleotides will hybridize with both wild-type and tRNA Lys3 anticodon variants, whereas the probes complementary to the anticodon arm are specific for each mutant tRNA Lys3 .
FIG. 1 Sequence of human tRNA Lys3 folded into the cloverleaf secondary structure. The arrows point to the anticodon mutations created in this work, and the mutant tRNA species are listed as well. Sequences complementary to the DNA hybridization probes are indicated by the solid lines . The probe complementary to the 3 ′ -18 nucleotides will hybridize with both wild-type and tRNA Lys3 anticodon variants, whereas the probes complementary to the anticodon arm are specific for each mutant tRNA Lys3 .CC-BY · From the PDF
FIG. 2 Expression of total tRNA Lys3 in cells and viruses. COS7 cells were transfected with a plasmid containing HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. Dot-blots of cellular or viral RNA, containing equal amounts of either 𝛃 -actin mRNA (cellular RNA) or genomic RNA (viral RNA), were hybridized with a DNA probe complementary to the 3 ′ -terminal 18 nucleotides of tRNA Lys3 to determine the total amount of tRNA Lys3 present ( A and B ). The top strip in panel A is a Dot-blot of increasing amounts of an in vitro tRNA Lys3 transcript used to generate the standard curve shown in panel B . The bottom two strips in panel A show Dot-blots of cellular or viral RNA isolated from cells transfected with HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. 1, cells transfected with HIV-1 DNA alone (BH10, also referred to as none in panels C and D ). Lanes 2 -6 represent cells transfected with HIV-1 DNA and tRNA Lys3 genes coding for the following anticodon sequences: 2 , SUU (wild type); 3 , CGA; 4 , CGU; 5 , SGU; 6 , SGA. The normalized results are plotted in panels C and D for cellular or viral RNA blots, respectively.
FIG. 2 Expression of total tRNA Lys3 in cells and viruses. COS7 cells were transfected with a plasmid containing HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. Dot-blots of cellular or viral RNA, containing equal amounts of either 𝛃 -actin mRNA (cellular RNA) or genomic RNA (viral RNA), were hybridized with a DNA probe complementary to the 3 ′ -terminal 18 nucleotides of tRNA Lys3 to determine the total amount of tRNA Lys3 present ( A and B ). The top strip in panel A is a Dot-blot of increasing amounts of an in vitro tRNA Lys3 transcript used to generate the standard curve shown in panel B . The bottom two strips in panel A show Dot-blots of cellular or viral RNA isolated from cells transfected with HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. 1, cells transfected with HIV-1 DNA alone (BH10, also referred to as none in panels C and D ). Lanes 2 -6 represent cells transfected with HIV-1 DNA and tRNA Lys3 genes coding for the following anticodon sequences: 2 , SUU (wild type); 3 , CGA; 4 , CGU; 5 , SGU; 6 , SGA. The normalized results are plotted in panels C and D for cellular or viral RNA blots, respectively.CC-BY · From the PDF
FIG. 3 Two-dimensional PAGE patterns of viral low molecular weight RNA. RNA was extracted from virions produced from COS7 cells transfected with a plasmid containing HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. The RNA was 3 ′ -end-labeled in vitro with [ 32 P]Cp and analyzed by twodimensional PAGE. A , cells transfected with HIV-1 DNA alone, i.e. containing only endogenous tRNA Lys3 (Endogenous). B -F , cells transfected with HIV-1 DNA and tRNA Lys3 genes containing the anticodon sequences listed above each panel. The numbers listed under each panel correspond to the tRNA Lys3 /tRNA Lys1,2 ratios and were determined by phosphorimaging.
FIG. 3 Two-dimensional PAGE patterns of viral low molecular weight RNA. RNA was extracted from virions produced from COS7 cells transfected with a plasmid containing HIV-1 proviral DNA and a wild-type or mutant tRNA Lys3 gene. The RNA was 3 ′ -end-labeled in vitro with [ 32 P]Cp and analyzed by twodimensional PAGE. A , cells transfected with HIV-1 DNA alone, i.e. containing only endogenous tRNA Lys3 (Endogenous). B -F , cells transfected with HIV-1 DNA and tRNA Lys3 genes containing the anticodon sequences listed above each panel. The numbers listed under each panel correspond to the tRNA Lys3 /tRNA Lys1,2 ratios and were determined by phosphorimaging.CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 7 Graph showing the correlation between tRNA Lys3 aminoacylation and incorporation into HIV-1. Letters in parentheses indicate the anticodon sequence of the tRNA Lys3 variants tested. These data are based on the quantitative results shown in Figs. 4 ( panel C ) and 6 ( panel F ).
FIG. 7 Graph showing the correlation between tRNA Lys3 aminoacylation and incorporation into HIV-1. Letters in parentheses indicate the anticodon sequence of the tRNA Lys3 variants tested. These data are based on the quantitative results shown in Figs. 4 ( panel C ) and 6 ( panel F ).CC-BY · From the PDF
Image 8
CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 50

Metadata

Authors
Javanbakht, H., Cen, S., Musier-Forsyth, K., & Kleiman, L.
Affiliations
Jewish General Hospital (CA)
Corresponding author
Kleiman, Lawrence
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-05
Volume
277
Issue
20
Pages
17389-17396
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1978749730
Cited by
49
References
31
Citations by year
2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 4
FWCI
1.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
aminoacylation, lysyl-tRNA synthetase, HIV-1 assembly, anticodon mutation, tRNA isoacceptors
MeSH terms
Animals, Anticodon, Base Sequence, Humans, Lysine-tRNA Ligase, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, RNA, Transfer, Lys, Transfection, Virion, Electrophoresis, Gel, Two-Dimensional, HIV-1, Virus Assembly, COS Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.